The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Age as a factor in the molecular landscape and the tumor-microenvironmental signature of osteosarcoma.
 
Andreas Seeber
Consulting or Advisory Role - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Andrew Elliott
Employment - Caris Life Sciences
 
Jaime Modiano
Honoraria - ImmunityBio
Research Funding - Boston Scientific
Patents, Royalties, Other Intellectual Property - Anivive Lifesciences; Boston Scientific; Kerafast
 
Gerold Untergasser
No Relationships to Disclose
 
Margaret von Mehren
Consulting or Advisory Role - deciphera; GlaxoSmithKline
Research Funding - ASCO (Inst); Deciphera (Inst); Genmab (Inst); Gradalis (Inst); Novartis (Inst); Solaris Health (Inst)
Patents, Royalties, Other Intellectual Property - cell line
Other Relationship - NCCN
 
Andrew Rosenberg
No Relationships to Disclose
 
Moh'd Khushman
No Relationships to Disclose
 
Don S. Dizon
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; i-Mab; Oasmia Pharmaceutical AB; Pfizer; Regeneron; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Kazia Therapeutics (Inst); Pfizer (Inst)
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - Bayer; Blueprint Medicines; Daiichi Sankyo; Deciphera; Ignyta; Loxo; NanoCarrier; SpringWorks Therapeutics
Research Funding - AADi (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); NanoCarrier (Inst); Philogen (Inst); Plexxikon (Inst); Roche/Genentech (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Ignyta; NanoCarrier
 
Jonathan C. Trent
Consulting or Advisory Role - Agios; Bayer; Blueprint Medicines; C4 Therapeutics; Daiichi Sankyo; Deciphera; Epizyme; Janssen; Lilly; Novartis
 
Kai Zimmer
No Relationships to Disclose
 
Galina Lagos
No Relationships to Disclose
 
Bradley DeNardo
No Relationships to Disclose
 
Aaron Sarver
No Relationships to Disclose
 
Alberto Puccini
No Relationships to Disclose
 
Phillip Walker
Employment - Caris Life Sciences
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Domink Wolf
No Relationships to Disclose
 
Florian Kocher
No Relationships to Disclose